Imexpharm Corporation (HOSE:IMP)
Vietnam · Delayed Price · Currency is VND 55,000
+1,000 (1.85%)
At close: Aug 15, 2025
Imexpharm Revenue
Imexpharm had revenue of 632.70B VND in the quarter ending June 30, 2025, with 22.33% growth. This brings the company's revenue in the last twelve months to 2.42T, up 16.33% year-over-year. In the year 2024, Imexpharm had annual revenue of 2.21T with 10.59% growth.
Revenue (ttm)
2,423.55B
Revenue Growth
+16.33%
P/S Ratio
3.50
Revenue / Employee
1.67B
Employees
1,452
Market Cap
8,470.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,205.12B | 211.08B | 10.59% |
| Jan 1, 2024 | 1,994.04B | 350.33B | 21.31% |
| Dec 31, 2022 | 1,643.71B | 377.11B | 29.77% |
| Dec 31, 2021 | 1,266.60B | -102.83B | -7.51% |
| Dec 31, 2020 | 1,369.42B | -33.03B | -2.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition